Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Int J Environ Res Public Health. 2021 Sep 18;18(18):9831. doi: 10.3390/ijerph18189831.
Osteoporosis and its complications are a major health concern in Saudi Arabia, and the prevalence of osteoporosis is on the rise. The aim of this study was to estimate the direct healthcare cost for patients with osteoporosis. A retrospective study was carried out among adult patients with osteoporosis in a teaching hospital in Saudi Arabia. A bottom-up approach was conducted to estimate the healthcare resources used and the total direct medical cost for the treatment of osteoporosis and related fractures. The study included 511 osteoporosis patients, 93% of whom were female. The average (SD) age was 68.5 years (10.2). The total mean direct medical costs for patients without fractures were USD 975.77 per person per year (PPPY), and for those with osteoporotic fractures, the total direct costs were USD 9716.26 PPPY, of which 56% of the costs were attributable to surgery procedures. Prior to fractures, the main cost components were medication, representing 61%, and physician visits, representing 18%. The findings of this study indicated the economic impact of osteoporosis and related fractures. With the aging population in Saudi Arabia, the burden of disease could increase significantly, which highlights the need for effective prevention strategies to minimize the economic burden of osteoporosis.
骨质疏松症及其并发症是沙特阿拉伯的一个主要健康关注点，骨质疏松症的患病率呈上升趋势。本研究旨在评估骨质疏松症患者的直接医疗保健成本。对沙特阿拉伯一家教学医院的成年骨质疏松症患者进行了回顾性研究。采用自下而上的方法来估算用于治疗骨质疏松症和相关骨折的医疗资源和总直接医疗费用。该研究共纳入 511 名骨质疏松症患者，其中 93%为女性。平均（SD）年龄为 68.5 岁（10.2）。无骨折患者的人均年直接医疗费用为 975.77 美元（PPPY），而患有骨质疏松性骨折的患者的直接总费用为 9716.26 美元（PPPY），其中 56%的费用归因于手术程序。在骨折之前，主要的费用构成部分是药物治疗，占 61%，其次是医生就诊，占 18%。本研究的结果表明了骨质疏松症及其相关骨折带来的经济影响。随着沙特阿拉伯人口老龄化，疾病负担可能会显著增加，这突显了需要有效的预防策略来减轻骨质疏松症的经济负担。
